Standard clinical dose escalation The FDA-approved Mounjaro (brand tirzepatide) follows this schedule: Weeks 1-4: 2.5 mg once weekly (starting dose, allows GI adaptation) Weeks 5-8: 5 mg once weekly (first therapeutic dose increase) Weeks 9-12: 7.5 mg once weekly (if tolerated and additional effect needed) Weeks 13-16: 10 mg once weekly (continued escalation) Weeks 17-20: 12.5 mg once weekly (approaching maximum) Week 21+: 15 mg once weekly (maximum approved dose) Each dose is maintained for at least four weeks before escalation
After washing three times with TBST (Tris-buffered saline supplemented with 0.1% Tween-20), the samples were incubated for 1 hour at room temperature with a secondary antibody
Cox SE, Ellins EA, Marealle AI, et al
Most common is injection site irritation (redness, swelling, or itching)
doi: 10.1016/J.METABOL.2020.154304 35 NatalicchioALabarbutaRTortosaFBiondiGMarranoNPeschecheraAet al
Kojic acid targets localized pigmentation or dark spots
